Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Global Forecast 2024-2030


Attention: There is an updated edition available for this report.

Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Global Forecast 2024-2030


The Hemostats Market size was estimated at USD 3.23 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 5.65% to reach USD 4.75 billion by 2030.

Global Hemostats MarketThe hemostats are a range of medical devices and products designed to control, prevent, and stop bleeding during surgical procedures and traumatic injuries. These devices play an important role in managing blood loss and facilitate proper tissue healing while reducing the risk of complications. Hemostats have applications in numerous surgical specialties, including cardiovascular surgery, general surgery, orthopedic surgery, neurosurgery, gynecologic surgery, and dental surgery. The growing occurrence of chronic diseases among an aging population drives the demand for surgeries that necessitate effective blood loss management solutions, consequently expanding the utilization of diverse hemostatic agents. Additionally, increasing inclination toward minimally invasive procedures with rising investments by government bodies and healthcare organizations to improve surgical infrastructure is raising the usage of hemostats. High R&D costs associated with developing breakthrough products and a high risk of contamination with hemostats hamper market growth. The increasing development of biologically compatible hemostats by market vendors that minimize adverse effects while providing effective bleeding control is expected to create opportunities for market growth.Regional InsightsThe growing number of surgical procedures with the rising availability of advanced healthcare facilities, especially across the U.S., Canada, and Brazil, are expanding the growth of the hemostats market in the Americas. According to the American Society of Plastic Surgeons, in 2022, a total of 1,017,003 reconstructive surgeries were performed, necessitating the use of hemostats. The emerging trend of medical tourism across Canada, Dubai, Singapore, Japan, and the UK is expanding the number of minimally invasive surgical procedures, thereby creating a platform for the hemostats market. According to the Medical Tourism Index survey (MTA), Canada is one of the preferred destinations, attracting around 14 million Americans from other nations. Ongoing advancements in healthcare infrastructure and technologies across European countries, with constant support from regulatory bodies such as the European Medicines Agency (EMA) on expanding the manufacturing of medical devices and healthcare infrastructure, are bolstering the European market. The Middle East & Africa region presents promising growth opportunities due to increasing healthcare expenditure and government initiatives towards modernizing healthcare infrastructure. Countries, including Saudi Arabia, the United Arab Emirates, and South Africa, are witnessing a surge in the need for effective hemostatic solutions with the rising number of surgical interventions. Moreover, increased government funding to expand the manufacturing of medical devices domestically across India, Australia, China, and Japan and increased awareness associated with minimally invasive surgeries are expected to bolster market growth in Asia-Pacific.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hemostats Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hemostats Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Collagen-Based Hemostats
Combination Hemostats
Gelatin-Based Hemostats
Oxidized Regenerated Cellulose-Based Hemostats
Thrombin-Based Hemostats
Formulation
Matrix & Gel Hemostats
Powder Hemostats
Sheet & Pad Hemostats
Sponge Hemostats
Application
Cardiovascular Surgery
General Surgery
Gynecological Surgery
Neurological Surgery
Orthopedic Surgery
Reconstructive Surgery
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hemostats Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hemostats Market?
3. What are the technology trends and regulatory frameworks in the Hemostats Market?
4. What is the market share of the leading vendors in the Hemostats Market?
5. Which modes and strategic moves are suitable for entering the Hemostats Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Hemostats Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic disorders with increasing need for surgical interventions
5.1.1.2. Growing inclination toward minimally invasive surgeries
5.1.2. Restraints
5.1.2.1. Rising incidences of product recalls
5.1.3. Opportunities
5.1.3.1. Rise of biopolymer-based disposable hemostats
5.1.3.2. Integration of nanotechnology to create more efficient and targeted hemostats
5.1.4. Challenges
5.1.4.1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
5.2. Market Segmentation Analysis
5.2.1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
5.2.2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
5.2.3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
5.3. Market Trend Analysis
5.3.1. Robust and improving healthcare infrastructure and availability of improved hemostats in the Americas region
5.3.2. Acceleration of medical tourism and expanding healthcare infrastructure with growing investment by the government in the Asia-Pacific
5.3.3. Increase in number of medical tourists coupled with strong foothold of major healthcare companies in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Hemostats Market, by Type
6.1. Introduction
6.2. Collagen-Based Hemostats
6.3. Combination Hemostats
6.4. Gelatin-Based Hemostats
6.5. Oxidized Regenerated Cellulose-Based Hemostats
6.6. Thrombin-Based Hemostats
7. Hemostats Market, by Formulation
7.1. Introduction
7.2. Matrix & Gel Hemostats
7.3. Powder Hemostats
7.4. Sheet & Pad Hemostats
7.5. Sponge Hemostats
8. Hemostats Market, by Application
8.1. Introduction
8.2. Cardiovascular Surgery
8.3. General Surgery
8.4. Gynecological Surgery
8.5. Neurological Surgery
8.6. Orthopedic Surgery
8.7. Reconstructive Surgery
9. Americas Hemostats Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hemostats Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hemostats Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
12.3.1.2. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
12.3.2. New Product Launch & Enhancement
12.3.2.1. Baxter Launches PERCLOT Absorbable Hemostatic Powder
12.3.2.2. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
12.3.3. Award, Recognition, & Expansion
12.3.3.1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
12.3.3.2. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
12.3.3.3. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
12.3.3.4. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
12.3.3.5. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
12.3.3.6. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. A.R. Medicom, Inc.
13.1.2. ACTEON Group
13.1.3. Advamedica Inc.
13.1.4. Advanced Medical Solutions Group PLC
13.1.5. Advin Health Care
13.1.6. Aegis Lifesciences Private Limited
13.1.7. Argon Medical Devices
13.1.8. B. Braun SE
13.1.9. Baxter International Inc.
13.1.10. Becton, Dickinson and Company
13.1.11. Betatech Medical
13.1.12. Convatec Group PLC
13.1.13. Cook Group Incorporated
13.1.14. Cortis Medtech Pvt Ltd
13.1.15. Cotran Corporation
13.1.16. Dolphin Sutures by Futura Surgicare Pvt. Ltd.
13.1.17. Dynarex Corporation
13.1.18. Gelita AG
13.1.19. Hangzhou Singclean Medical Products Co.,Ltd.
13.1.20. Healthium Medtech Ltd
13.1.21. Hemostasis, LLC
13.1.22. Integra LifeSciences Holdings Corporation
13.1.23. Johnson & Johnson Services, Inc.
13.1.24. Medcura, Inc.
13.1.25. Medline Industries, LP
13.1.26. Medprin Biotech GmbH
13.1.27. Medtronic PLC
13.1.28. Meril Life Sciences Pvt. Ltd.
13.1.29. Olympus Corporation
13.1.30. Pfizer Inc.
13.1.31. Rousselot BV by Darling Ingredients International Holding B.V.
13.1.32. Royal DSM
13.1.33. Shilpa Medicare Limited
13.1.34. Stapleline Medizintechnik GmbH
13.1.35. Stryker Corporation
13.1.36. SYMATESE
13.1.37. Teleflex Incorporated
13.1.38. Terumo Corporation
13.1.39. Zhejiang Perfectseal New Material Technology Co., Ltd.
13.1.40. Zimmer Biomet Holdings, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. HEMOSTATS MARKET RESEARCH PROCESS
FIGURE 2. HEMOSTATS MARKET SIZE, 2023 VS 2030
FIGURE 3. HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HEMOSTATS MARKET DYNAMICS
FIGURE 7. HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 10. HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings